Wilson v. Brown & Williamson Tobacco Corp.

968 F. Supp. 296, 1997 U.S. Dist. LEXIS 9277, 1997 WL 366054
CourtDistrict Court, S.D. West Virginia
DecidedJune 27, 1997
DocketCivil Action 5:96-2029
StatusPublished
Cited by5 cases

This text of 968 F. Supp. 296 (Wilson v. Brown & Williamson Tobacco Corp.) is published on Counsel Stack Legal Research, covering District Court, S.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wilson v. Brown & Williamson Tobacco Corp., 968 F. Supp. 296, 1997 U.S. Dist. LEXIS 9277, 1997 WL 366054 (S.D.W. Va. 1997).

Opinion

MEMORANDUM OPINION AND ORDER

HADEN, Chief Judge.

Plaintiff Wayne Wilson, Sr., filed an eleven count complaint against Brown & Williamson (“B & W”) seeking compensation for injuries he sustained as a result of his use of Bugler, a loose tobacco product manufactured and sold by B & W. Wilson states he smoked Bugler from 1960 to 1995. B & W moves to dismiss all but Counts Six (breach of express warranty) and Ten (damages). For the reasons that follow, the Court GRANTS in part and DENIES in part the motion.

I. THE “DUTY TO WARN” CLAIMS

B & W urges the Court dismiss Counts Two, Three, Four, Five, Seven and Eight, 1 which it asserts generally allege B & W failed to warn or inform adequately of the health risks associated with smoking, for two alternative reasons. First, B & W argues *298 these claims are preempted by the Federal Cigarette Labeling and Advertising Act of 1965 (“FCLAA” or “Act”), 15 U.S.C. § 1331 et seq., as amended. Second, B & W contends that because the risks associated with smoking are well known, West Virginia law imposes no duty to warn of such dangers.

A. Federal preemption

In response to growing concern about the health risks associated with cigarette smoking, Congress in 1965 enacted the FCLAA. 2 The current version of the FCLAA states the purpose of the statute is

to establish a comprehensive program to deal with cigarette labeling and advertising with respect to any relationship between smoking and health, whereby—
(1) the public may be adequately informed about any adverse health effects of cigarette smoking by inclusion of warning notices on each package of cigarettes and in each advertisement of cigarettes; and
(2) commerce and the national economy may be (A) protected to the maximum extent consistent wdth this declared policy and (B) not impeded by diverse, nonuniform, and confusing cigarette labeling and advertising regulations with respect to any relationship between smoking and health.

15 U.S.C. § 1331.

The FCLAA requires the now-familiar Surgeon General’s Warning to appear in a conspicuous place on every cigarette package manufactured, imported or packaged for sale or distribution within the United States. 15 U.S.C. § 1333.

The statute contains an express preemption clause, which reads:

(a) No statement relating to smoking and health, other than the statement required by section 1333 of this title, shall be required on any cigarette package.
(b) No requirement or prohibition based on smoking and health shall be imposed under State law with respect to the advertising or promotion of any cigarettes the packages of which are labeled in conformity with the provisions of this chapter.
The FCLAA defines “cigarettes” as
(A) any roll of tobacco wrapped in paper or in any substance not containing tobacco, and
(B) any roll of tobacco wrapped in any substance containing tobacco which, because of its appearance, the type of tobacco used in the filler, or its packaging and labeling, is likely to be offered to, or purchased by, consumers as a cigarette described in subparagraph (A).

Id. § 1332(1). This definition makes clear that the statute’s labeling requirement does not apply to loose tobacco products such as Bugler. Bugler products in fact do not contain the warning on their labels.

While B & W acknowledges loose tobacco products are not covered by the FCLAA’s labeling requirement, it argues Congress in enacting the statute “apparently decided to preempt all claims relating to tobacco warnings.” Reply at 3. B & W offers numerous unpublished and ultimately unpersuasive decisions in support of its contention. 3

*299 Much of B & Ws argument rests on Cipollone v. Liggett Group, Inc., 505 U.S. 504, 112 S.Ct. 2608, 120 L.Ed.2d 407 (1992), where the Supreme Court first examined the preemptive reach of the FCLAA. In Cipollone, the son of a longtime cigarette smoker sought recovery under various common law theories against the manufacturers of cigarettes his deceased mother smoked for many years. The manufacturers defended that the 1965 and 1969 Acts preempted the plaintiffs claims. The Court held the 1965 Act preempted none of the plaintiffs claims. A plurality of justices held the 1969 Act preempted:

claims based on failure to warn and the neutralization of federally mandated warnings to the extent that those claims rely on omissions or inclusions in [the manufacturers’] advertising or promotions; the 1969 Act does not pre-empt [plaintiffs] claims based on express warranty, intentional fraud and misrepresentation, or conspiracy.

505 U.S. at 530-31, 112 S.Ct. at 2625.

To reach these conclusions, the Court began by stating the general preemption principles. The “ultimate touchstone” of preemption analysis is the purpose of Congress. Cipollone, 505 U.S. at 516, 112 S.Ct. at 2618 (internal quotations omitted). This intent may be

explicitly stated in the statute’s language or implicitly contained in its structure and purpose. In the absence of an express congressional command, state law is preempted if that law actually conflicts with federal law, or if federal law so thoroughly occupies a legislative field as to make reasonable the inference that Congress left no room for the States to supplement it.

Id. (internal quotations and cited authority omitted); see also Cavallo v. Star Enterprise, 100 F.3d 1150, 1155 (4th Cir.1996).

The Court then described the task at hand: “[W]e must fairly but — in light of the strong presumption against pre-emption — narrowly construe the precise language of § 5(b) and we must look to each of petitioner’s common law claims to determine whether it is in fact pre-empted.” 505 U.S. at 523, 112 S.Ct. at 2621. The “central inquiry,” according to the Court, was “whether the legal duty that is the predicate of the common law damages action constitutes a ‘requirement based on smoking and health ... imposed under state law with respect to advertising or promotion[.]’ ” Id. at 523-24, 112 S.Ct. at 2621 (quoting 15 U.S.C. § 1334).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Raab v. Smith & Nephew, Inc.
150 F. Supp. 3d 671 (S.D. West Virginia, 2015)
Beattie v. Skyline Corp.
906 F. Supp. 2d 528 (S.D. West Virginia, 2012)
Keffer v. Wyeth
791 F. Supp. 2d 539 (S.D. West Virginia, 2011)
Roney v. Gencorp
654 F. Supp. 2d 501 (S.D. West Virginia, 2009)
Little v. Brown & Williamson Tobacco Corp.
243 F. Supp. 2d 480 (D. South Carolina, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
968 F. Supp. 296, 1997 U.S. Dist. LEXIS 9277, 1997 WL 366054, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wilson-v-brown-williamson-tobacco-corp-wvsd-1997.